Fluconazole Tablet

DRUG2 trials

Sponsors

Eli Lilly and Company, Scynexis, Inc.

Conditions

HealthyRecurrent Vulvovaginal Candidiasis

Phase 1

A Drug Interaction Study of LY3154207 in Healthy Participants

CompletedNCT03942029

Eli Lilly and CompanyHealthy

Start: 2019-06-21End: 2019-12-28Updated: 2020-01-18

Phase 3

Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)

CompletedNCT04029116

Scynexis, Inc.Recurrent Vulvovaginal Candidiasis

Start: 2019-10-21End: 2021-11-29Updated: 2023-06-18